6.
Feng W, Ao H, Peng C, Yan D
. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019; 142:176-191.
DOI: 10.1016/j.phrs.2019.02.024.
View
7.
Zhang Y, Liu Q, Yu Y, Wang M, Wen C, He Z
. Early and Short-Term Interventions in the Gut Microbiota Affects Lupus Severity, Progression, and Treatment in MRL/lpr Mice. Front Microbiol. 2020; 11:628.
PMC: 7171286.
DOI: 10.3389/fmicb.2020.00628.
View
8.
Ju T, Kong J, Stothard P, Willing B
. Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota. ISME J. 2019; 13(6):1520-1534.
PMC: 6776049.
DOI: 10.1038/s41396-019-0364-5.
View
9.
Costantini D, Marasco V, Moller A
. A meta-analysis of glucocorticoids as modulators of oxidative stress in vertebrates. J Comp Physiol B. 2011; 181(4):447-56.
DOI: 10.1007/s00360-011-0566-2.
View
10.
Wang H, Wang G, Banerjee N, Liang Y, Du X, Boor P
. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice. Front Immunol. 2021; 12:651191.
PMC: 8071869.
DOI: 10.3389/fimmu.2021.651191.
View
11.
Yue S, Wang W, Yu J, Chen Y, Shi X, Yan D
. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach. Pharmacol Res. 2019; 148:104453.
DOI: 10.1016/j.phrs.2019.104453.
View
12.
Jiao Y, Wu L, Huntington N, Zhang X
. Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases. Front Immunol. 2020; 11:282.
PMC: 7047319.
DOI: 10.3389/fimmu.2020.00282.
View
13.
Zhang Y, Song F, Yang M, Chen C, Cui J, Xing M
. Gastrointestinal Dysmotility Predisposes to Colitis through Regulation of Gut Microbial Composition and Linoleic Acid Metabolism. Adv Sci (Weinh). 2024; 11(20):e2306297.
PMC: 11132037.
DOI: 10.1002/advs.202306297.
View
14.
Nguyen-Khac E, Thevenot T, Piquet M, Benferhat S, Goria O, Chatelain D
. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011; 365(19):1781-9.
DOI: 10.1056/NEJMoa1101214.
View
15.
Lightstone L, Doria A, Wilson H, Ward F, Larosa M, Bargman J
. Can we manage lupus nephritis without chronic corticosteroids administration?. Autoimmun Rev. 2017; 17(1):4-10.
DOI: 10.1016/j.autrev.2017.11.002.
View
16.
Li D, Pan Y, Xia X, Liang J, Liu F, Dou H
. Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells. Eur J Pharmacol. 2020; 884:173421.
DOI: 10.1016/j.ejphar.2020.173421.
View
17.
Gao X, Wang J, Li M, Wang J, Lv J, Zhang L
. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. J Cell Mol Med. 2019; 23(10):6797-6804.
PMC: 6787507.
DOI: 10.1111/jcmm.14560.
View
18.
Guo M, Wang H, Xu S, Zhuang Y, An J, Su C
. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020; 11(6):1758-1773.
PMC: 7524333.
DOI: 10.1080/19490976.2020.1768644.
View
19.
Tsokos G
. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020; 21(6):605-614.
PMC: 8135909.
DOI: 10.1038/s41590-020-0677-6.
View
20.
Edgar R
. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26(19):2460-1.
DOI: 10.1093/bioinformatics/btq461.
View